TSBX Turnstone Biologics Net earnings per share growth this year

TSBX (turnstonebio.com) - company brandmark

Turnstone Biologics (TSBX) plans to generate revenue through the implementation of innovative TIL cell therapy against solid tumors. The annual earnings per share volatility metric helps avoid speculative peaks, with the current parameter equal to 0.00. Growth is driven by unique cell selection and TIDAL-01 tests. Future revenues are protected by patents, guaranteeing the company high pricing power in immuno-oncology.

Turnstone Biologics Corp. (TSBX): Net earnings per share growth this year from 02/21/2024 to 08/24/2025

Analytical breakdowns and data insights for company turnstonebio.com (TSBX)

- current quotes and average value forecast:
Market Chart Turnstone Biologics Corporation|TSBX - Price Target Chart
- market capitalization data:
Market Valuation Turnstone Biologics Corp.|TSBX - Total Company Value
- company book value details:
Accounting Value per Share Turnstone Biologics|TSBX - Company Net Assets|Market Capitalization to Book Value Ratio turnstonebio.com|TSBX - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio Turnstone Biologics|TSBX - Long-Term Debt to Equity|Current Liabilities to Capital Turnstone Biologics|TSBX - Company Total Debt|Debt to Net Assets Turnstone Biologics Corp|TSBX - Company Long-Term Liabilities|Amount of Current Liabilities Turnstone Biologics|Intermediate Coverage Ratio turnstonebio.com
- net income and valuation ratios data:
TSBX - Net Profit|Expected Net Profit Turnstone Biologics|TSBX - Price to Earnings Ratio|Future Price to Earnings Multiple Turnstone Biologics Corp|TSBX - PEG Multiple|EV/EBITDA Multiple Turnstone Biologics Corp.|TSBX - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Turnstone Biologics|TSBX - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months turnstonebio.com|TSBX - Net earnings per share growth this year|Projected earnings per share increase next year Turnstone Biologics
- company sales and revenue statistics:
TSBX - Company Sales|Projected Sales Volume Turnstone Biologics Corporation|TSBX - Price-to-Revenue Ratio|Forward Price to Sales Turnstone Biologics Corp.|TSBX - Sales Growth YoY (Last Twelve Months)
Summary company analysis:TSBX (Turnstone Biologics Corp.)
Brand item of Turnstone Biologics

This indicator measures the net income per share dynamics over twelve months, reflecting the efficiency of the business capitalization. For Turnstone Biologics (TSBX), the annual EPS percentage change depends not on market cycles, but on progress in immuno-oncology and R&D success. Monitoring this metric allows an investor to recognize the degradation of fundamentals in a timely manner and protect capital from asset depreciation.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year sonnetbio.com (SONN)|MAIA: Earnings per share trend in current year|Liminatus Pharma Inc. - Net earnings per share growth this year|LAVA Therapeutics N.V. (LVTX) - Earnings per share growth rate in current year|NXTC - Earnings per share growth in current year|LPTX: Earnings per share growth in current year|Intensity Therapeutics (INTS) - Earnings per share growth in current year|Earnings per share growth rate in current year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth in current year|Gritstone bio (GRTS) - Expected net earnings per share growth this year|Earnings growth in current year KA|Expected net earnings per share growth this year NexImmune Inc|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year